Menu
Back to Journals » ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
Editor-in-Chief: Professor Giorgio Colombo
An international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
- Emerging Sources Citation Index (ESCI), from 2016
- PubMed and PubMed Central (Clinicoecon Outcomes Res)
- Embase, from 2009 (Correct as at December 8, 2016)
- Scopus, from 2009 (Correct as at December 8, 2016)
- Directory of Open Access Journals (DOAJ)
- OAIster - The Open Access Initiative
Articles:
- View all (655)
- Volume 13, 2021 (26)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Latest articles:
- 5 records -
Policy Responses and Social Solidarity Imperatives to Respond the COVID-19 Pandemic Socioeconomic Crises in Ethiopia
Angaw KW
ClinicoEconomics and Outcomes Research 2021, 13:279-287
Published Date: 22 April 2021
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J
ClinicoEconomics and Outcomes Research 2021, 13:263-277
Published Date: 22 April 2021
Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs
Mehta D, Davis M, Epstein AJ, Wensel B, Grinnell T, Williams GR
ClinicoEconomics and Outcomes Research 2021, 13:251-261
Published Date: 19 April 2021
Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
Tokunaga K, Suzuki C, Hasegawa M, Fujimori I
ClinicoEconomics and Outcomes Research 2021, 13:241-250
Published Date: 16 April 2021
Factors and Economic Outcomes Associated with Documented Difficult Intubation in the United States
Moucharite MA, Zhang J, Giffin R
ClinicoEconomics and Outcomes Research 2021, 13:227-239
Published Date: 1 April 2021